SCHEMBL3214843

SCHEMBL3214843

CC(C)Oc1cc(N(Cc2cccnc2)c2ccc(C(=O)OC(C)(C)C)cc2)ccc1OC(F)F

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 8/20 0.41
PDE4B Q07343 5/20 0.39
PDE4A P27815 4/20 0.38
PDE4C Q08493 4/20 0.38
PDE4D Q08499 4/20 0.38
POLB P06746 2/20 0.38
HPGD P15428 1/20 0.38
LMNA P02545 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 1/20 0.37
PDK2 Q15119 1/20 0.37
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
MEN1 O00255 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NR3C2 P08235 1/20 0.35
PDK1 Q15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4201416 0.96 PDE4B (0.41) GRM2PDE4BPDE4APDE4CPDE4D
SCHEMBL3126155 0.93 GRM2 (0.43) GRM2PDE4BPDE4APDE4CPDE4D
SCHEMBL3264902 0.93 GRM2 (0.36) GRM2PDE4B
SCHEMBL3128977 0.92 ALDH1A1 (0.43) PDE4BPDE4APDE4CPDE4DPOLB
SCHEMBL3120607 0.91 PDE4B (0.39) GRM2PDE4BPDE4APDE4CPDE4D
SCHEMBL3126325 0.90 RXRA (0.38) PDE4BPDE4APDE4CPDE4DMAPT
SCHEMBL4196553 0.90 GRM2 (0.40) GRM2PDE4BPDE4APDE4CPDE4D
SCHEMBL3129936 0.88 KMT2A (0.39) GRM2PDE4BPDE4APDE4CPDE4D
SCHEMBL3121497 0.88 RXRA (0.48) GRM2PDE4BPDE4APDE4CPDE4D
SCHEMBL3133561 0.87 GRM2 (0.42) GRM2PDE4BPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B GRM2 3498/4885PDE4B 2/4885PDE4A 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.